These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21083697)

  • 1. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint.
    Achike FI; To NH; Wang H; Kwan CY
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):1-10. PubMed ID: 21083697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, blood vessels and metabolic syndrome.
    Tesauro M; Cardillo C
    Acta Physiol (Oxf); 2011 Sep; 203(1):279-86. PubMed ID: 21439028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neuropeptides in appetite regulation and obesity--a review.
    Arora S; Anubhuti
    Neuropeptides; 2006 Dec; 40(6):375-401. PubMed ID: 16935329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.
    Blaj S; Stanciu S; Jurcut C; Ciobîcă L
    Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction.
    Guzik TJ; Marvar PJ; Czesnikiewicz-Guzik M; Korbut R
    J Physiol Pharmacol; 2007 Dec; 58(4):591-610. PubMed ID: 18195475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and signalling role of adipose tissue: new perspectives on fat.
    Trayhurn P
    Acta Physiol Scand; 2005 Aug; 184(4):285-93. PubMed ID: 16026420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and the metabolic syndrome.
    Vega GL
    Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and metabolic syndrome.
    Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brown adipose tissue: a promising target to combat obesity.
    Vernochet C; McDonald ME; Farmer SR
    Drug News Perspect; 2010 Sep; 23(7):409-17. PubMed ID: 20862392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?
    Trayhurn P; Wang B; Wood IS
    Br J Nutr; 2008 Aug; 100(2):227-35. PubMed ID: 18397542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White adipose tissue as endocrine organ and its role in obesity.
    Vázquez-Vela ME; Torres N; Tovar AR
    Arch Med Res; 2008 Nov; 39(8):715-28. PubMed ID: 18996284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.